Phase Ib Study of Duligotuzumab (mehd7945a) Plus Cisplatin/5-Fluorouracil or Carboplatin/Paclitaxel for First-Line Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Cancer（2016）
Key words
antibody,clinical trial,duligotuzumab,epidermal growth factor receptor (EGFR),human epidermal growth factor receptor 3 (HER3)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined